It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
Tech Xplore on MSN
New AI system fixes 3D printing defects in real time
Additive manufacturing has revolutionized manufacturing by enabling customized, cost-effective products with minimal waste. However, with the majority of 3D printers operating on open-loop systems, ...
History may soon repeat itself with a novel new platform: networks of AI agents carrying out instructions from prompts and sharing them with other AI agents, which could spread the instructions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results